Health
Could synNotch CAR T cells be the answer to fighting solid tumours? – Drug Target Review
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
Posted: 22 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
A novel chimeric antigen receptor T-cell (CAR T) therapy targeting neuroblastoma effectively killed cancer cells while sparing healthy tissues in pre-clinical studies. While this work is in the preclinical phase, the developers of the treatment said it opens the door for other potentially…
-
Noosa News23 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General22 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News16 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News15 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party